Avenue Therapeutics (NASDAQ:ATXI) Shares Scheduled to Reverse Split on Friday, April 26th

Shares of Avenue Therapeutics, Inc. (NASDAQ:ATXI) are going to reverse split on Friday, April 26th. The 1-75 reverse split was announced on Friday, April 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, April 26th.

Avenue Therapeutics Trading Down 29.6 %

Avenue Therapeutics stock traded down $0.04 during mid-day trading on Wednesday, hitting $0.09. The company had a trading volume of 12,284,611 shares, compared to its average volume of 4,543,282. Avenue Therapeutics has a 12 month low of $0.09 and a 12 month high of $1.25. The stock’s 50 day moving average price is $0.15 and its two-hundred day moving average price is $0.21. The company has a market capitalization of $4.17 million, a PE ratio of -0.07 and a beta of -0.24.

Avenue Therapeutics (NASDAQ:ATXI) last announced its quarterly earnings results on Monday, March 18th. The company reported $0.56 earnings per share (EPS) for the quarter.

Avenue Therapeutics Company Profile

Avenue Therapeutics, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.